Tubulin polymerization activator-1
Tubulin polymerization activator-1 is a Tubulin polymerization promoter. Tubulin polymerization activator-1 induces Apoptosis, G2/M phase cell cycle arrest, and mitochondrial membrane potential depolarization. Tubulin polymerization activator-1 inhibits angiogenesis. Tubulin polymerization activator-1 exhibits anticancer activity against prostate cancer, melanoma, and cervical cancer. Tubulin polymerization activator-1 can be used for research on prostate cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C27H25NO7
- Molecular Weight:475.49
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PC-3 | IC50 |
0.02 μM
|
Antiproliferative activity against human PC-3 prostate cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Antiproliferative activity against human PC-3 prostate cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
42647402 |
| HeLa | IC50 |
0.13 μM
|
Antiproliferative activity against human HeLa cervical cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Antiproliferative activity against human HeLa cervical cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
42647402 |
| U-87MG ATCC | IC50 |
4.71 μM
|
Antiproliferative activity against human U87 MG glioblastoma cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Antiproliferative activity against human U87 MG glioblastoma cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
42647402 |
| HT-1080 | IC50 |
1.13 μM
|
Antiproliferative activity against human HT1080 fibrosarcoma cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Antiproliferative activity against human HT1080 fibrosarcoma cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
42647402 |
| A549 | IC50 |
1.46 μM
|
Antiproliferative activity against human A549 lung cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Antiproliferative activity against human A549 lung cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
42647402 |
In Vitro
Tubulin polymerization activator-1 (Compound 5d) (48 h) exhibited potent antiproliferative activity against PC-3, D24, and HeLa cancer cell lines, with the strongest activity against PC-3 cells (IC50 = 0.02 μM)[1].
Tubulin polymerization activator-1 (0.025-0.1 μM; 10 days) inhibits the clonogenic growth of PC-3 cells in a dose-dependent manner[1].
Tubulin polymerization activator-1 (0.025-0.05 μM; 24 h) induces dose-dependent G2/M phase cell cycle arrest in PC-3 cells[1].
Tubulin polymerization activator-1 (0.025-0.1 μM; 24 h) induces apoptosis in PC-3 cells, manifesting as characteristic nuclear morphological changes[1].
Tubulin polymerization activator-1 (0.025-0.1 μM; 48 h) inhibits the migration of HUVEC cells[1].
Tubulin polymerization activator-1 (0.05-0.1 μM; 6 h) effectively inhibits angiogenesis in HUVECs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:PC-3
-
Concentration:0.025-0.05 μM
-
Incubation Time:24 h
-
Result:Arrested the cell cycle at the G2/M phase in a dose-dependent manner.
Increased the percentage of cells in the G2/M phase to 34.4% at a concentration of 0.05 μM.
-
Cell Line:PC-3
-
Concentration:0.025-0.1 μM
-
Incubation Time:24 h
-
Result:Induced distinct alterations in the nuclear structure of PC-3 cells, including fragmented and shrunken nuclei, which are indicative of apoptosis.
Chemical Information
-
Molecular Weight 475.49
-
Formel C27H25NO7
-
SMILES
O=C(/C=C/C1=CC=C([N+]([O-])=O)C=C1)/C(C2=CC(OC)=C(OC)C(OC)=C2)=C/C3=CC=C(OC)C=C3
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Human pluripotent stem cell endothelial-cell differentiation
Human pluripotent stem cell endothelial differentiation is based on stepwise developmental patterning: early activation of WNT/GSK3β inhibition promotes mesodermal or vascular progenitor entry, followed by endothelial specification using VEGF-related signaling, BMP4, FGF2, Notch modulation, or cAMP depending on the published protocol. Endothelial differentiation is read out by acquisition of CD31, CD34, VE-cadherin/CD144, KDR/VEGFR2, vWF, Tie2, NOS3, acetylated LDL uptake, tube/network formation, barrier function, and in vivo vessel-forming capacity where tested.
-
Vascular/Branching Fractal Analysis
Vascular/branching fractal analysis quantifies the geometric complexity of vessel trees or vascular networks from segmented 2D images, commonly by converting vessels into binary and/or skeletonized maps and estimating fractal dimension using box-counting or related approaches. Fractal dimension is interpreted as an image-derived readout of vascular branching complexity, space filling, or density, and has been applied to retinal photographs, fluorescein angiography, OCT angiography, capillary perfusion maps, and in vitro Matrigel angiogenesis networks. The assay readout is generated from vessel-positive pixels after image preprocessing, vessel segmentation, binarization, and optional skeletonization; reported outputs include fractal dimension, vessel density, branchpoint density, endpoint density, vessel length density, tortuosity, and generation-based branching metrics when VESGEN-style analysis is used. The biological interpretation is limited to quantitative vascular patterning and s
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Endothelial Cell Migration/Angiogenic Sprouting Assay
Endothelial cell migration and angiogenic sprouting assays are in vitro (and partially ex vivo-adapted) functional models that quantify the ability of endothelial cells to undergo coordinated migration, extracellular matrix invasion, and multicellular organization into capillary-like sprouts in response to pro-angiogenic stimuli such as VEGF, bFGF, or conditioned microenvironments. These assays are used to model early angiogenic events including tip-cell formation, directional migration, and lumen-like sprout extension, which collectively reflect angiogenic activation and vascular morphogenesis processes observed in vivo.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Tubulin polymerization activator-1
- Tubulin polymerization activator1
- Tubulin polymerization activator 1
- Microtubule/Tubulin
- Apoptosis
- Mitochondrial Metabolism
- HUVEC migration
- reactive oxygen species
- mitochondrial membrane potential depolarization
- G2/M phase cell cycle arrest
- PC-3 cells
- tubulin polymerization
- tubulin-binding microtubule-stabilizing agent
- angiogenesis
- apoptosis
- prostate cancer
- Inhibitor
- inhibitor
- inhibit